GE Healthcare Zeroes In On Cath Lab With Partnering Strategy
This article was originally published in The Gray Sheet
Executive Summary
GE Healthcare is embarking on a series of strategic partnerships with device firms to increase its footprint in coronary catheterization labs
You may also be interested in...
Volcano Ready To Erupt? Vascular Imaging Start-Up Lures Big-Time Partners
Ultrasound catheter firm Volcano Corp. only went public in June, but it has already attracted noticeable interest from the top players in the device industry
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.